维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Muul LM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，23：	1
2	Observations on the systemic administration of autologous Iymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，23：	1
3	Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM		0，，23：	1
4	Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components:long-term results of the first clinical gene therapy trial显示文摘	Muul LM Tuschong LM Soenen SL	2003	Blood2003，101，7：	1
5	A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone显示文摘	RosenbergSA LotzeMT Muul LM	1987	N Engl J Med1987，316，9：	1
6	In vitro studies on the cell - mediated immune response to human brain tumors and leukocyt induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack 显示文摘	Gately CL Muul LM Greenwood MA	1984	J Immunol1984，133，6：	1
7	A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone 显示文摘	ROSENBERG SA LOTZE MT MUUL LM	1987	N Engl J Med1987，316，15：	1
8	A pro- cess report on the treatment of 157 pa- tients with advanced cancer using lym- phokine-activated killer cells and inter- leukin-2 or high-dose interleukin-2 alone 显示文摘	Rosenberg SA Lotze MT Muul LM	1987	N Engl J Meal1987，316，：	1
9	Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial显示文摘	Tuschong LM Soenen SL	2003	Blood2003，101，7：	1
10	Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer 显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，23：	1
11	A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone显示文摘	Rosenberg SA Lotze MT Muul LM	1987	N Engl J Med1987，316，：	1
12	Observationson the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patientswith metastatic cancer 显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，23：	1
13	Observations on the systemic administration of autologous lymphokine- activated killer cells and recombinant interleukin-2 to pa- tients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，23：	1
14	In vitro studies on the cell-mediated immune reponse to human brain tumors and leukocyto -induced coats of glycosaminoglycan increase the resistance of glioma cells cellular immune attack显示文摘	Gately CL Muul LM Grcenwood MA	1984	J Immunol1984，133，6：	1
15	Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N EnglJ Med1985，313，23：	1
16	Observationst hesystemic administ rations of autologous lymphokineactivated killer cells and recombinant interleukin 22 to patients with metastatic cancer显示文摘	Rosenberg SA Lotze MT Muul LM	1985	N Engl J Med1985，313，：	1
17	Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘	Rosenberg SA Muul LM Leitman S	1985	N Engl J Med1985，313，：	1
18	Observations on the systemic administration of autologous lymphokine-activated killer cells and re- combinant interleukin-2 to patients with metastatic cancer 显示文摘	Rosenberg SA Lotze MT Muul LM et o/	1985	N Engl J Med1985，313，23：	1
19	Identification of specific cytolytic immune response against tumor in humans bearing malignant melanoma显示文摘	Muul LM Spiess PJ Director EP	1987	J Immunol1987，138，3：	1
20	Observations on the sys- temic administration of autologous lymphokine activated killer cells and recombinant interlenkin-2 to patients with metastatic cancer 显示文摘	Rosenberg SA Lotze NIT Muul LM	1985	New Engl J Med1985，313，23：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示